TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 93 filers reported holding TCR2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48 | -65.7% | 31,683 | -77.4% | 0.00% | – |
| Q4 2022 | $140 | -100.0% | 140,041 | -47.8% | 0.00% | – |
| Q3 2022 | $483,000 | -47.7% | 268,130 | -15.8% | 0.00% | -100.0% |
| Q2 2022 | $923,000 | +235.6% | 318,416 | +220.1% | 0.00% | – |
| Q1 2022 | $275,000 | -95.9% | 99,469 | -93.1% | 0.00% | -100.0% |
| Q4 2021 | $6,735,000 | +113.2% | 1,445,317 | +289.4% | 0.00% | +200.0% |
| Q3 2021 | $3,159,000 | +245.2% | 371,167 | +565.1% | 0.00% | – |
| Q2 2021 | $915,000 | -72.1% | 55,807 | -62.4% | 0.00% | -100.0% |
| Q1 2021 | $3,275,000 | -78.6% | 148,343 | -70.0% | 0.00% | -81.8% |
| Q4 2020 | $15,308,000 | +13.9% | 494,928 | -25.1% | 0.01% | -35.3% |
| Q3 2020 | $13,434,000 | +2091.5% | 661,101 | +1555.6% | 0.02% | +1600.0% |
| Q2 2020 | $613,000 | +11.5% | 39,930 | -43.8% | 0.00% | 0.0% |
| Q1 2020 | $550,000 | -23.3% | 71,098 | +41.6% | 0.00% | 0.0% |
| Q4 2019 | $717,000 | -64.6% | 50,212 | -64.5% | 0.00% | -66.7% |
| Q2 2019 | $2,024,000 | -51.7% | 141,435 | -41.2% | 0.00% | -50.0% |
| Q1 2019 | $4,194,000 | – | 240,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |